Testing a smart pill dispenser for chronic conditions
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study will test a smart pill dispenser (Mobili®) that helps people with diabetes or heart conditions remember to take their medications on time. It's for adults who take at least two oral pills and are comfortable using a smartphone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have diabetes or a heart condition
- You take at least two regular oral medications (pills/capsules)
- You can use a smartphone
- Only one person per household can take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special pill that has a sensor inside, which sends information to your doctor or care team to help you remember to take your HIV medication. It is for people who sometimes miss doses and want extra support.
This study tests whether family-focused coaching and easy-to-read materials can improve heart failure medication adherence. It also uses an electronic pillbox to track how consistently you take your meds, with your care partner involved.
This study tests a mobile health app called eDrugSafe to help people manage their medications better. If you take multiple medications, this app may help you keep track of them and learn more about your treatments.
This study tests a device that reminds you to take your dementia medications and alerts a trusted caregiver if doses are missed. The goal is to help prevent medication mix-ups and keep you healthier.
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
This trial is testing whether a telemedicine program combined with smart insulin pens can help improve blood sugar control. It is for people with diabetes who use multiple daily insulin injections and have a smartphone.
Hear when a new Medication Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.